01 January 2002
Comorbid disease profiles of adults with end-stage hip osteoarthritis.
Ray Marks, John P AllegranteMed Sci Monit 2002; 8(4): CR305-309 :: ID: 420863
Abstract
BACKGROUND: Although hip osteoarthritis is a common disabling condition,an incomplete understanding of all factors that contribute to hip osteoarthritis disability persists.The objective of the study was to improve our understanding of potentially preventable factors that mightinfluence hip osteoarthritis disability by examining the prevalence and impact of selected comorbid factorspotentially associated with the progression and severity of hip joint osteoarthritis among patients withend-stage hip osteoarthritis. MATERIAL/METHODS: The medical records of 1,000 hip osteoarthritis surgicalpatients were assessed to specifically identify the presence or absence of comorbid conditions of thecardiac, vascular or respiratory systems. The association between the patient's functional status beforeand after surgery, and the presence or absence of these comorbid conditions, was assessed. RESULTS: Over55% of the sample had at least one comorbid condition, such as hypertension or cardiac disease. Aftercontrolling for age, trauma, type of surgery and gender discrepancies, those with two or more comorbiditieswere found to have greater degrees of functional impairment before surgery, and lower post-operativefunctional status after surgery than those with no co-existent disease (p<0.05).
Conclusions: Patients with end-stage hip osteoarthritis exhibit a high prevalence of vascular-related comorbidities. The disability of patients with hip osteoarthritis is increased in the presence of two or more related comorbid conditions. These findings suggest a novel focus for primary, secondary and tertiary preventive strategies.
Keywords: Aged, 80 and over, Comorbidity, Diabetes Mellitus, Hypertension, Neoplasms, New York City, Obesity, Osteoarthritis, Hip, Prevalence, Respiration Disorders
Editorial
01 March 2025 : Editorial
Editorial: The World Health Organization (WHO) Updated List of Emerging and Potentially Pandemic Pathogens Includes Yersinia pestis as Plague Vaccines Await Clinical TrialsDOI: 10.12659/MSM.948672
Med Sci Monit 2025; 31:e948672
In Press
Clinical Research
Exploring the Association Between Serum Neurogranin, Nardilysin, and Ischemic Stroke: A Case-Control Study ...Med Sci Monit In Press; DOI: 10.12659/MSM.947703
Clinical Research
Comparative Analysis of Laser Therapies for Striae Distensae: Fractional CO₂ vs Combined Q-Switch Nd:YAGMed Sci Monit In Press; DOI: 10.12659/MSM.947464
Database Analysis
Utility of Central Venous Oxygen Saturation Gradient in Predicting Mortality in Dialysis with Catheter AccessMed Sci Monit In Press; DOI: 10.12659/MSM.947298
Clinical Research
Intraoperative Renal Near-Infrared Spectroscopy Monitoring as a Predictor of Renal Outcomes in Cardiac SurgeryMed Sci Monit In Press; DOI: 10.12659/MSM.947462
Most Viewed Current Articles
17 Jan 2024 : Review article 7,094,149
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research 702,321
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Mar 2024 : Editorial 27,595
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and ...DOI :10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
28 Jan 2024 : Review article 21,787
A Review of IgA Vasculitis (Henoch-Schönlein Purpura) Past, Present, and FutureDOI :10.12659/MSM.943912
Med Sci Monit 2024; 30:e943912